Airikkala, M.I.

vaccine group iscom vaccinated virus infection herpesviru titre iscom vaccinated group challenge response vaccination antibody development animal fhv –cat model cdv vaccinated cats iscom vaccine peak virus titres challenge infection signi symptom candidate t-cell osterhaus adme t-cell responses vaccinated groups disease discharge fhv cat system control phocid osterhau model serum fhv infection signi ficantly dilution level protein throat preparation system score candidate phhv martina signi ficant reduction puri fied rgb rehabilitation contrast electron microscopy virus excretion 5 days od 450 nm virus titres cytopathic changes neutralising study protection iscom group ef ficacy speci control group herpe ficant cdv vaccinated group 943–948 fhv iscom group centre netherland b.e.e strain proliferative reduction presence ficantly ficacy antigen t-lymphocyte plate rehabilitation centres